Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Invest Ophthalmol Vis Sci ; 58(14): 6065-6071, 2017 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-29204645

RESUMO

Purpose: Conjunctival melanoma (CM) is a rare malignant disease that can lead to recurrences and metastases. There is a lack of effective treatments for the metastases, and we set out to develop a new animal model to test potential therapies. Zebrafish are being used as a model for many diseases, and our goal was to test whether this animal could be used to study CM. Methods: Three human CM cell lines (CRMM-1 and CM2005.1, which both harbor a B-RAF mutation, and CRMM-2, which has an N-RAS mutation) were injected into the yolk sac, around the eye, and into the duct of Cuvier of transgenic (fli:GFP) Casper zebrafish embryos. Fluorescent and confocal images were taken to assess the phenotype and the behavior of engrafted cells and to test the effect of Vemurafenib as a treatment against CM. Results: While the cells that had been injected inside the yolk sac died and those injected around the eye sporadically went into the circulation, the cells that had been injected into the duct of Cuvier colonized the zebrafish: cells from all three cell lines proliferated and disseminated to the eyes, where they formed clusters, and to the tail, where we noticed extravasation and micrometastases. Vemurafenib, a potent agent for treatment of B-RAF V600E-positive melanoma, inhibited outgrowth of CRMM-1 and CM2005.1 cells in a mutation-dependent way. Conclusions: The (fli:GFP) Casper zebrafish embryo can be used as an efficient animal model to study metastatic behavior of human CM cells and warrants further testing of drug efficacy to aid care of CM patients.


Assuntos
Proteína Reguladora de Apoptosis Semelhante a CASP8 e FADD/genética , Neoplasias da Túnica Conjuntiva/genética , DNA de Neoplasias/genética , Melanoma/genética , Mutação , Animais , Animais Geneticamente Modificados , Proteína Reguladora de Apoptosis Semelhante a CASP8 e FADD/metabolismo , Linhagem Celular Tumoral , Movimento Celular , Proliferação de Células , Neoplasias da Túnica Conjuntiva/embriologia , Neoplasias da Túnica Conjuntiva/metabolismo , Análise Mutacional de DNA , Humanos , Imuno-Histoquímica , Melanoma/embriologia , Melanoma/metabolismo , Neoplasias Experimentais , Peixe-Zebra/embriologia
2.
Autophagy ; 11(3): 581-2, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25837021

RESUMO

The discovery that heterozygous disruption of Becn1 in mice leads to spontaneous tumor development was the first direct link arguing for a predominantly tumor-suppressor function of autophagy. However, the mechanisms by which BECN1 restrains tumorigenesis and whether autophagy-independent functions of BECN1 contribute to its tumor-restraining potential remained unexplored. We recently described a novel function of BECN1-regulation of oncogene MCL1 protein levels. Our results show that BECN1 regulates MCL1 levels in an inverse-reciprocal manner, whereby changes in the levels of one of the 2 proteins inversely affects the proteasomal degradation of the other. Importantly, this mechanism is independent of autophagy and of the physical interaction between BECN1 and MCL1. In vitro and in vivo analysis using several models, including patient-derived melanoma cells and tissue samples from patients with melanocytic lesions at different stages, showed that the identified mechanism of inverse coregulation between BECN1 and MCL1 significantly contributes to their opposing roles in tumorigenesis.


Assuntos
Proteínas Reguladoras de Apoptose/metabolismo , Autofagia , Proteínas de Membrana/metabolismo , Proteína de Sequência 1 de Leucemia de Células Mieloides/metabolismo , Animais , Apoptose , Proteína Beclina-1 , Carcinogênese , Linhagem Celular Tumoral , Endopeptidases/metabolismo , Perfilação da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Heterozigoto , Humanos , Melanócitos/metabolismo , Melanoma/embriologia , Camundongos , Oncogenes , Fenótipo , Complexo de Endopeptidases do Proteassoma/metabolismo , Neoplasias Cutâneas/metabolismo , Ubiquitina Tiolesterase/metabolismo
3.
Invest Ophthalmol Vis Sci ; 55(10): 6612-22, 2014 Sep 23.
Artigo em Inglês | MEDLINE | ID: mdl-25249605

RESUMO

PURPOSE: Uveal melanoma (UM) is fatal in up to 50% of patients because of liver metastases that are refractory to therapies currently available. While murine xenograft models for human uveal melanoma are available, they have limited utility for screening large compound libraries in drug discovery studies. Therefore, new robust preclinical models are needed that can efficiently evaluate drug efficacy for treatment of this malignancy. METHODS: Uveal melanoma cell lines generated from primary tumors (92.1, Mel270) and metastases (OMM2.3, OMM2.5, OMM1) were injected into the yolk of 2-day-old zebrafish embryos. After 6 days, proliferation and active migration was quantified via automated confocal image analysis. To determine the suitability of this xenotransplantation model for drug testing, drugs with three different activities (dasatinib, quisinostat, and MLN-4924) were added to the water of uveal melanoma-engrafted embryos. RESULTS: All tested UM cell lines proliferated and migrated in the embryos; significant differences could be discerned between cell lines: Cells derived from metastases showed more migration and proliferation than cells derived from the primary tumors, and provided preclinical models for drug testing. Addition of the Src-inhibitor dasatinib in the water of engrafted embryos reduced proliferation and migration of high Src-expressing 92.1 cells, but did not affect low Src-expressing metastatic OMM2.3 cells. Two experimental anticancer drugs, quisinostat (a histone deacetylase inhibitor) and MLN-4924 (neddylation pathway inhibitor), blocked migration and proliferation of 92.1 and OMM2.3. CONCLUSIONS: We established a zebrafish xenograft model of human uveal melanoma with demonstrated applicability for screening large libraries of compounds in drug discovery studies.


Assuntos
Antineoplásicos/uso terapêutico , Melanoma/embriologia , Neoplasias Experimentais/embriologia , Neoplasias Uveais/embriologia , Animais , Movimento Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Xenoenxertos , Humanos , Melanoma/tratamento farmacológico , Células Tumorais Cultivadas , Neoplasias Uveais/tratamento farmacológico , Peixe-Zebra/embriologia
4.
Pigment Cell Melanoma Res ; 26(5): 746-54, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23789776

RESUMO

We hypothesize that the interaction between angiotropic melanoma cells and the abluminal vascular surface can induce or sustain embryonic and/or stem cell migratory properties in these tumor cells. As a result, such angiotropic melanoma cells may migrate along the abluminal vascular surface, demonstrating pericytic mimicry. Through these cellular interactions, melanoma cells may migrate toward secondary sites.


Assuntos
Melanoma/embriologia , Melanoma/patologia , Mimetismo Molecular , Pericitos/patologia , Neoplasias Cutâneas/embriologia , Neoplasias Cutâneas/patologia , Animais , Movimento Celular , Humanos , Melanoma/irrigação sanguínea , Neovascularização Patológica , Crista Neural/patologia , Neoplasias Cutâneas/irrigação sanguínea
5.
Pigment Cell Melanoma Res ; 25(4): 446-53, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22574862

RESUMO

Melanocytes are pigment cells that are closely associated with many skin disorders, such as vitiligo, piebaldism, Waardenburg syndrome, and the deadliest skin cancer, melanoma. Through studies of model organisms, the genetic regulatory network of melanocyte development during embryogenesis has been well established. This network also seems to be shared with adult melanocyte regeneration and melanoma formation. To identify chemical regulators of melanocyte development and homeostasis, we screened a small-molecule library of 6000 compounds using zebrafish embryos and identified five novel compounds that inhibited pigmentation. Here we report characterization of two compounds, 12G9 and 36E9, which disrupted melanocyte development. TUNEL assay indicated that these two compounds induced apoptosis of melanocytes. Furthermore, compound 12G9 specifically inhibited the viability of mammalian melanoma cells in vitro. These two compounds should be useful as chemical biology tools to study melanocytes and could serve as drug candidates against melanocyte-related diseases.


Assuntos
Desenvolvimento Embrionário/efeitos dos fármacos , Melanócitos/patologia , Bibliotecas de Moléculas Pequenas/farmacologia , Peixe-Zebra/embriologia , Animais , Apoptose/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Forma Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Embrião não Mamífero/efeitos dos fármacos , Embrião não Mamífero/metabolismo , Embrião não Mamífero/patologia , Humanos , Melanócitos/efeitos dos fármacos , Melanócitos/metabolismo , Melanoma/embriologia , Melanoma/patologia , Camundongos , Pigmentação/efeitos dos fármacos , Bibliotecas de Moléculas Pequenas/química , Imagem com Lapso de Tempo
6.
Methods Cell Biol ; 105: 309-37, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21951536

RESUMO

Zebrafish provide an exciting animal model system for the study of human cancers. During the last few years many zebrafish models of cancer have been generated that recapitulate human hematologic malignancies and solid tumors. Concurrent technological advances have significantly improved the genetic tractability and unique advantage of in vivo imaging in zebrafish, providing a means to dissect the molecular pathways underlying tumor initiation, progression and metastasis. Comparisons of cancer-associated gene expression profiles have demonstrated a high degree of similarity in the gene signatures of specific types of tumor cells in fish and humans, indicating that the contributing genetic pathways leading to cancer are evolutionarily conserved. Furthermore, the high fecundity, optical clarity and small embryo size of zebrafish continue to make it particularly amenable to performing whole-organism small molecule screens to identify targets for therapeutic development. This chapter reviews a wide array of these zebrafish cancer models and illustrates the advantages of the zebrafish system for exploring the molecular mechanisms governing cancer-related cellular processes.


Assuntos
Transformação Celular Neoplásica/genética , Técnicas de Transferência de Genes , Ensaios de Triagem em Larga Escala , Oncologia/métodos , Mutagênese/genética , Metástase Neoplásica , Proteínas Supressoras de Tumor/deficiência , Peixe-Zebra/genética , Animais , Transformação Celular Neoplásica/metabolismo , Modelos Animais de Doenças , Descoberta de Drogas , Embrião não Mamífero , Perfilação da Expressão Gênica , Humanos , Leucemia/embriologia , Leucemia/genética , Leucemia/patologia , Melanócitos/metabolismo , Melanócitos/patologia , Melanoma/embriologia , Melanoma/genética , Melanoma/patologia , Metástase Neoplásica/genética , Neoplasias Pancreáticas/embriologia , Neoplasias Pancreáticas/genética , Neoplasias Pancreáticas/patologia , Rabdomiossarcoma/embriologia , Rabdomiossarcoma/genética , Rabdomiossarcoma/patologia , Bibliotecas de Moléculas Pequenas/química , Bibliotecas de Moléculas Pequenas/farmacologia , Proteínas Supressoras de Tumor/genética , Peixe-Zebra/embriologia , Peixe-Zebra/metabolismo
7.
Cas Lek Cesk ; 149(12): 572-5, 2010.
Artigo em Tcheco | MEDLINE | ID: mdl-21387582

RESUMO

Mutual epithelial-mesenchymal interaction represents a fundamental control mechanism during the development of organs and tissues. This review article demonstrates the importance of such interaction for tumor formation where it influences the biological properties of cancer stem cell and tumor itself. The teratoma and melanoma are employed as examples to demonstrate the influence of embryonic microenvironment on the biological properties of tumor, mainly on its potential to metastasize. The manipulation of cancer microenvironment represents the perspective therapeutic tool for cancer treatment in future.


Assuntos
Neoplasias/embriologia , Células-Tronco Neoplásicas/fisiologia , Animais , Transformação Celular Neoplásica , Humanos , Melanoma/embriologia , Neoplasias/fisiopatologia , Teratoma/embriologia
8.
J Cell Physiol ; 222(1): 38-41, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19795394

RESUMO

Melanocytes are pigment-producing cells in the skin of humans and other vertebrates. A number of genes involved in melanocyte development and vertebrate pigmentation have been characterized, largely through studies of a diversity of pigment mutations in a variety of species. Embryonic development of the melanocyte initiates with cell fate specification in the neural crest, which is then followed by cell migration and niche localization. Many genes involved in melanocyte development have also been implicated in the development of melanoma, an aggressive and fatal form of skin cancer that originates in the melanocyte. Although early stage melanomas that have not spread to the lymph nodes can be excised with little risk of recurrence, patients diagnosed with metastatic melanoma have a high mortality rate due to the resistance of most tumors to radiotherapy and chemotherapy. Transformed melanocytes that develop into melanomas proliferate abnormally and often begin to grow radially in the skin. Vertical growth can then follow this radial growth, leading to an invasion through the basement membrane into the underlying dermis and subsequent metastasis. It is still unclear, however, how a normal melanocyte becomes a melanoma cell, and how melanoma utilizes the properties of the normal melanocyte and its progenitors in its progression. The goal of this mini-review is to highlight the role of melanocyte developmental pathways in melanoma, and to discuss recent studies and tools being used to illuminate this connection.


Assuntos
Desenvolvimento Embrionário , Melanócitos/citologia , Melanoma/embriologia , Melanoma/patologia , Animais , Humanos , Melanócitos/metabolismo , Melanoma/metabolismo , Transdução de Sinais
10.
Klin Khir (1962) ; (12): 18-20, 1994.
Artigo em Ucraniano | MEDLINE | ID: mdl-9173118

RESUMO

Experience of treatment of 36 patients with extramedullary spinal cord tumors is summarized. Pigmented macules, papillomas or the spinous processes painfulness while irritation were determined on skin in accordance to tumor localization in the innervation zone of one or two segments.


Assuntos
Melanoma/etiologia , Recidiva Local de Neoplasia/etiologia , Neurilemoma/etiologia , Neoplasias da Medula Espinal/etiologia , Adulto , Idoso , Terapia Combinada , Feminino , Humanos , Melanoma/embriologia , Melanoma/cirurgia , Recidiva Local de Neoplasia/embriologia , Recidiva Local de Neoplasia/cirurgia , Neurilemoma/embriologia , Neurilemoma/cirurgia , Cuidados Pós-Operatórios , Neoplasias da Medula Espinal/embriologia , Neoplasias da Medula Espinal/cirurgia
11.
Int Ophthalmol ; 7(3-4): 143-7, 1985 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-3997355

RESUMO

On the basis of two cases the relation between 'neurogenic' tumours (neurinomas, neurilemmomas, Schwannomas, neurofibromas) and malignant melanomas of the uvea is discussed with emphasis on the close association of both groups of neoplasms with the ciliary nerves. The great histopathological diversity between different cases of melanoma as well as within individual cases is also pointed out. On histological and cytological criteria it may be difficult to differentiate between the 'neurogenic' tumours and the highly differentiated, spindle cell variants of the melanomas. Since all these tumours are derived from the neural crest, they might be grouped under one common heading. It is postulated that 'neurogenic' tumours have been overdiagnosed to the disadvantage of the highly differentiated spindle cell melanomas.


Assuntos
Melanoma/embriologia , Crista Neural/fisiologia , Neoplasias Uveais/embriologia , Idoso , Neoplasias Oculares/patologia , Feminino , Humanos , Masculino , Melanoma/classificação , Melanoma/patologia , Microscopia Eletrônica , Pessoa de Meia-Idade , Neoplasias/patologia , Doenças do Nervo Óptico/patologia , Neoplasias Uveais/classificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA